LOJACONO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 8.025
EU - Europa 4.321
AS - Asia 3.736
SA - Sud America 658
Continente sconosciuto - Info sul continente non disponibili 233
AF - Africa 94
OC - Oceania 15
Totale 17.082
Nazione #
US - Stati Uniti d'America 7.893
CN - Cina 1.365
SG - Singapore 1.264
UA - Ucraina 813
DE - Germania 763
PL - Polonia 683
IT - Italia 619
BR - Brasile 550
HK - Hong Kong 416
FR - Francia 334
GB - Regno Unito 256
FI - Finlandia 249
RU - Federazione Russa 220
VN - Vietnam 181
TR - Turchia 135
IE - Irlanda 130
IN - India 109
EE - Estonia 93
BD - Bangladesh 88
MX - Messico 55
CA - Canada 43
SE - Svezia 37
ZA - Sudafrica 36
AR - Argentina 32
IQ - Iraq 25
EC - Ecuador 22
BE - Belgio 21
NL - Olanda 20
ID - Indonesia 19
JP - Giappone 19
NG - Nigeria 19
SA - Arabia Saudita 18
ES - Italia 17
AU - Australia 14
PK - Pakistan 14
UZ - Uzbekistan 14
AT - Austria 13
CO - Colombia 13
CL - Cile 10
JM - Giamaica 10
EG - Egitto 9
EU - Europa 8
UY - Uruguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
IR - Iran 6
KZ - Kazakistan 6
TT - Trinidad e Tobago 6
JO - Giordania 5
MU - Mauritius 5
NP - Nepal 5
PE - Perù 5
PY - Paraguay 5
BG - Bulgaria 4
BH - Bahrain 4
HN - Honduras 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
RS - Serbia 4
AL - Albania 3
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MY - Malesia 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
Totale 16.844
Città #
Fairfield 815
Woodbridge 710
Singapore 696
Warsaw 679
Ashburn 620
Jacksonville 576
Houston 443
Hong Kong 410
Ann Arbor 344
Chandler 323
Cambridge 319
San Jose 306
Seattle 303
Beijing 284
Wilmington 284
The Dalles 247
Princeton 245
Nanjing 220
New York 207
Los Angeles 205
Buffalo 135
Helsinki 132
Dublin 130
Istanbul 112
Lauterbourg 107
Columbus 101
Tallinn 93
Nanchang 83
Des Moines 67
Dearborn 66
Milan 63
Ho Chi Minh City 61
Moscow 60
São Paulo 60
Shenyang 56
Lancaster 53
Munich 53
Hebei 47
San Diego 46
Changsha 45
Rome 43
Shanghai 42
Brescia 38
Verona 38
Santa Clara 36
Jinan 35
San Francisco 35
Tianjin 35
Hanoi 34
Dallas 33
Jiaxing 29
Chicago 28
Chennai 27
Nürnberg 26
Hangzhou 25
Council Bluffs 24
Redondo Beach 23
London 22
Zhengzhou 22
Guangzhou 21
Brussels 20
Denver 20
Genova 20
Phoenix 20
Abuja 19
Tokyo 19
Dong Ket 18
Johannesburg 18
Naples 18
Orem 18
Taizhou 17
Rio de Janeiro 16
Belo Horizonte 14
Boardman 14
Ningbo 14
Brasília 13
Brooklyn 13
Mexico City 13
Mumbai 13
Poplar 13
Tashkent 13
Turku 13
Dhaka 12
Monterrey 12
Toronto 12
Amsterdam 11
Baghdad 11
Charlotte 11
Guayaquil 11
Kunming 11
Lanzhou 11
Nuremberg 11
Falkenstein 10
Manchester 10
Montreal 10
Porto Alegre 10
Riyadh 10
Auburn Hills 9
Boston 9
Florence 9
Totale 10.968
Nome #
Bambini pretermine: nati per vivere 365
Parto e puerperio: i vissuti delle donne in un'ottica di ricerca multidisciplinare. 336
Variabili psicologiche materne e andamento del parto: rilevazione in un campione di donne italiane alla prima esperienza di parto. 335
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 328
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 321
Percorso nascita: un progetto di ricerca multidisciplinare. 294
Long-term outcome of children of rheumatic disease patients 234
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 213
L’approccio multidisciplinare alla nascita: parto, puerperio, visti dalle donne. 203
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 192
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 191
Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise 188
Dinoprostone per l'induzione del travaglio di parto in pazienti con Bishop score favorevole: confronto tra gel vaginale e pessario vaginale a rilascio prolungato 183
Children born to SLE and APS mothers 181
L’approccio multidisciplinare alla nascita: parto e puerperio visti dalle donne. 177
A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score 170
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 170
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 169
Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study 167
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 165
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 163
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 163
Uterine artery velocimetry in patients with gestational hypertension 161
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 161
Prophylactic oral nifedipine to reduce preterm delivery: a randomized controlled trial in women at high risk 159
Labor course and delivery in epidural analgesia: a case-control study 158
Pregnancy complications of the antiphospholipid syndrome 157
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies 157
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 154
Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. 152
Neuropsychological development of children born to patients with systemic lupus erythematosus 150
Impact of in utero environment on the offspring of lupus patients 150
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 149
Offspring of Women with Systemic Autoimmune diseases: fetal and neonatal complications and inheritance of autoimmune diseases. 148
Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases 147
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 147
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 146
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 146
Predictors of maternal and fetal complications in SLE patients: a prospective study 145
Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease 144
Neonatal outcome in patients with rheumatic disease 142
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 142
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 142
Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study 140
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 138
Neonatal effects of maternal antiphospholipid syndrome. 137
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents 136
European registry of babies born to mothers with antiphospholipid syndrome. 136
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome 135
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. 134
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and in preeclampsia 134
Neuropsychological development of children born to patients with antiphospholipid syndrome. 133
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 133
Infertility in women with systemic autoimmune diseases 133
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 132
Assistenza e sorveglianza nel travaglio di parto a basso rischio 131
Pregnancy and neonatal outcome in primary antiphospholipid syndrome. 129
The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. 129
Autoantibodies and prediction of reproductive failure. 127
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 126
Neonates born from mothers with autoimmune disorders 125
Anti-{beta}2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? 124
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction 123
Complement Activation and Pregnancy Failure. 122
Variabili psicologiche materne e andamento clinico del parto 122
Anti beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome 120
Transabdominal uterine arteries Doppler between 11-14 weeks of gestation for prediction of outcome in high risk pregnancies 120
Is it possible to differentiate "Natural" Antiphospholipid antibodies from "Thrombophilic" ones? Analysis of the fine specificity against the domains of Beta2glycoprotein I 119
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 117
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome 117
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 117
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 117
Autoimmune diseases and pregnancy 117
Pregnancy in systemic sclerosis: a prospective study 116
IgG anti-B2glycoprotein I antibodies form one-year-old children born to mothers with systemic autoimmune diseases preferentially target domain 4/5 115
External cephalic version for breech presentation at term: an effective procedure to reduce the caesarean section rate 114
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 114
THE FINE SPECIFICITY OF ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES IS PREFERENTIALLY DIRECTED AGAINST DOMAIN 1 113
LA FINE SPECIFICITA' DEGLI ANTICORPI ANTI-BETA2GLICOPROTEINA I NELLE MALATTIE AUTOIMMUNI SISTEMICHE E' PREVALENTEMENTE DIRETTA ERSO IL DOMINIO 1 112
Finespecificity of anti-B2glycoprotein I antibodies in sysemic autoimmune diseasesis mostly directed against domain 1 112
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 112
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 110
Outcome of infants from mothers with anti-SSA/Ro antibodies. 110
Esperienza personale nel trattamento delle emorragie gastroduodenali mediante l'associazione di somatostatina e ranitidina 110
ANTICORPI ANTIFOSFOLIPIDI: E' POSSIBILE DISTINGUERE GLI ANTICORPI "INNOCENTI" DA QUELLI "TROMBOFILICI"? ANALISI DELLA FINE SPECIFICITA' DIRETTA VERSO I DOMINI DELLA BETA2GLICOPROTEINA I 110
Gestational success in patients at risk of preterm labor with presence of ureaplasma urealyticum in cervico-vaginal secretions 108
Systemic lupus erythematosus and pregnancy: a prospective study. 108
Novel aspects of Sjögren’s syndrome in 2012 107
Thrombophilia is a risk factor for severe preeclampsia and its recurrence 106
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 106
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 105
ONE-YEAR-OLD CHILDREN BORN TO MOTHERS WITH SYSTEMIC AUTOIMMUNE DISEASES MAY DEVELOP ANTI-BETA2GPI IGG ANTIBODIES THAT PREFERENTIALLY TARGET DOMAIN 4/5 103
Contraception in adolescents with systemic lupus erythematosus 102
Obstetric manifestation of the Antiphospholipid Syndrome 102
One-year-old children born to mothers with systemic autoimmune diseases may develop anti-beta2GPI IGg antibodies that preferentially target domain 4/5 102
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 102
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. 102
Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin 100
Clinical followup and screening for autoimmune disorders in patients with previous severe early onset preeclampsia 99
PROPOSTA DI UNA TECNOLOGIA OSTETRICA: IL PIANO DI ASSISTENZA OSTETRICA NELLA SORVEGLIANZA DEL BENESSERE MATERNO/FETALE INTRAPARTUM 98
Totale 14.786
Categoria #
all - tutte 76.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022910 0 169 18 49 13 50 38 67 41 119 93 253
2022/20231.017 138 7 26 78 104 261 4 105 173 5 42 74
2023/2024859 75 27 50 71 36 158 33 37 217 15 2 138
2024/20252.102 9 26 14 342 213 198 177 85 199 134 431 274
2025/20264.088 377 596 397 577 357 262 615 125 228 342 140 72
2026/2027265 219 46 0 0 0 0 0 0 0 0 0 0
Totale 17.082